Effects of transgenic overproduction of CRH on anxiety-like behaviour

European Journal of Neuroscience

Volumn 15, Issue 12, 2002, Pages 2007-2015

  Van Gaalen, Marcel M ^a,c   Stenzel Poore, Mary P ^b   Holsboer, Florian ^a   Steckler, Thomas ^a,d  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; DIAZEPAM; SEDATIVE AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONDITIONING; CONTROLLED STUDY; DRUG EFFECT; EXPLORATORY BEHAVIOR; FEAR; FLUID INTAKE; FORCED SWIMMING TEST; HORMONE RELEASE; LEARNING; LICKING; LIGHT DARK CYCLE; LOCOMOTION; MALE; MOTOR ACTIVITY; MOTOR COORDINATION; MOUSE; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; OPEN FIELD BEHAVIOR; PAIN THRESHOLD; PRIORITY JOURNAL; SEDATION; SENSORIMOTOR FUNCTION; STRESS; TASK PERFORMANCE;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; BRAIN; BRAIN CHEMISTRY; CORTICOTROPIN-RELEASING HORMONE; DARK ADAPTATION; DIAZEPAM; DRINKING; EXPLORATORY BEHAVIOR; FEAR; GENETIC PREDISPOSITION TO DISEASE; MALE; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; NEURONS; PAIN THRESHOLD; PHOTIC STIMULATION; REACTION TIME; STRESS; UP-REGULATION;

EID: 0036460685     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2002.02040.x     Document Type: Article

References (35)

1. Belzung, C. & Le Pape, G. (1994) Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety. Physiol. Behav., 56, 623-628.
2. Beuzen, A. & Belzung, C. (1995) Link between emotional memory and anxiety states: A study by principal component analysis. Physiol. Behav., 58, 111-118.
3. Borsini, F., Brambilla, A., Cesana, R. & Donetti, A. (1993) The effect of DAU 6215, a novel 5HT-3 antagonist, in animal models of anxiety. Pharmacol. Res., 27, 151-164.
4. Britton, K.T., Akwa, Y., Spina, M. & Koob, G.F. (2000) Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze. Peptides, 21, 37-44.
5. Britton, K.T., Morgan, J., Rivier, J., Vale, W. & Koob, G.F. (1985) Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test. Psychopharmacology, 86, 170-174.
6. Britton, D.R., Varela, M., Garcia, A. & Rosenthal, M. (1986) Dexamethasone suppresses pituitary-adrenal but not behavioral effects of centrally administered CRF. Life Sci., 38, 211-216.
7. Butler, P.D., Weiss, J.M., Stout, J.C. & Nemeroff, C.B. (1990) Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J. Neurosci., 10, 176-183.
8. Conti, L.H., Costello, D.G., Martin, L.A., White, M.F. & Abreu, M.E. (1994) Mouse strain differences in the behavioral effects of corticotropin-releasing factor (CRF) and the CRF antagonist alpha-helical CRF9-41. Pharmacol. Biochem. Behav., 48, 497-503.
9. De Souza, E.B. (1995) Corticotropin-releasing factor receptors: Physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology, 20, 789-819.
10. Dunn, A.J. & Berridge, C.W. (1990) Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses? Brain Res. Rev., 15, 71-100.
11. Ferre, P., Fernandez-Teruel A., Escorihuela, R.M., Garcia, E., Zapata, A. & Tobena, A. (1994) Struggling and flumazenil effects in the swimming test are related to the level of anxiety in mice. Neuropsychobiology, 29, 23-27.
12. Griebel, G., Belzung, C., Misslin, R. & Vogel, E. (1993) The free-exploratory paradigm: An effective method for measuring neophobic behaviour in mice and testing potential neophobia-reducing drugs. Behav. Pharmacol., 4, 637- 644.
13. Griebel, G., Belzung, C., Perrault, G. & Sanger, D.J. (2000) Differences in anxiety-related behaviour and sensititvity to diazepam in inbred and outbred strains of mice. Psychopharmacology, 148, 164-170.
14. Griebel, G., Perrault, G. & Sanger, D.J. (1997) CCK receptor antagonists in animal models of anxiety: Comparison between exploration tests, conflict procedures and a model based on defensive behaviours. Behav. Pharmacol., 8, 549-560.
15. Griebel, G., Perrault, G., Tan, S., Schoemaker, H. & Sanger, D.J. (1999) Pharmacological studies on synthetic flavonoids: Comparison with diazepam. Neuropharmacology, 38, 965-977.
16. Grigoriadis, D.E., Pearsall, D. & De Souza, E.B. (1989) Effects of chronic antidepressant and benzodiazepine treatment on corticotropin-releasing-factor receptors in rat brain and pituitary. Neuropsychopharmacology, 2, 53-60.
17. Heinrichs, S.C., Min, H., Tamraz, S., Carmouche, M., Boehme, S.A. & Vale, W.W. (1997) Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated. Psychoneuroendocrinology, 22, 215-224.
18. Heinrichs, S.C., Stenzel-Poore, M.P., Gold, L.H., Battenberg, E., Bloom, F.E., Koob, G.F., Vale, W.W. & Pich, E.M. (1996) Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor. Neuroscience, 74, 303-311.
19. Holsboer, F. (1999) The rationale for corticotropin-releasing hormone receptor (CRH-R.) antagonists to treat depression and anxiety. J. Psychiat. Res., 33, 181-214.
20. Jones, D.N., Kortekaas, R., Slade, P.D., Middlemiss, D.N. & Hagan, J.J. (1998) The behavioural effects of corticotropin-releasing factor-related peptides in rats. Psychopharmacology, 138, 124-132.
21. Killcross, S., Robbins, T.W. & Everitt, B.J. (1997) Different types of fear-conditioned behaviour mediated by separate nuclei within amygdala. Nature, 388, 377-380.
22. Koob, G.F. & Heinrichs, S.C. (1999) A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res., 848, 141-152.
23. Kopp, C., Vogel, E. & Misslin, R. (1999) Comparative study of emotional behaviour in three inbred strains of mice. Behav. Processes, 47, 161-174.
24. Menard, J. & Treit, D. (1999) Effects of centrally administered anxiolytic compounds in animal models of anxiety. Neurosci. Biobehav. Rev., 23, 591-613.
25. Rodgers, R.J. (1997) Animal models of 'anxiety': Where next?. Behav. Pharmacol., 8, 477-496.
26. Sherman, J.E. & Kalin, N.H. (1986) ICV-CRH potently affects behavior without altering antinociceptive responding. Life Sci., 39, 433-441.
27. Sirinathsinghji, D.J. & Heavens, R.P. (1989) Stimulation of GABA release from the rat neostriatum and globus pallidus in vivo by corticotropin-releasing factor. Neurosci. Lett., 100, 203-209.
28. Steckler, T. & Holsboer, F. (1999) Corticotropin-releasing hormone receptor subtypes and emotion. Biol. Psychiat., 46, 1480-1508.
29. Stenzel-Poore, M.P., Cameron, V.A., Vaughan, J., Sawchenko, P.E. & Vale, W. (1992) Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology, 130, 3378-3386.
30. Stenzel-Poore, M.P., Heinrichs, S.C., Rivest, S., Koob, G.F. & Vale, W.W. (1994) Overproduction of corticotropin-releasing factor in transgenic mice: A genetic model of anxiogenic behavior. J. Neurosci., 14, 2579-2584.
31. Sutton, R.E., Koob, G.F., Le Moal, M., Rivier, J. & Vale, W. (1982) Corticotropin releasing factor produces behavioural activation in rats. Nature, 297, 331-333.
32. Takeda, H., Tsuji, M. & Matsumiya, T. (1998) Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice. Eur. J. Pharmacol., 350, 21-29.
33. Treit, D., Pesold, C. & Rotzinger, S. (1993) Dissociating the anti-fear effects of septal and amygdaloid lesions using two pharmacologically validated models of rat anxiety. Behav. Neurosci., 107, 770-785.
34. van Gaalen, M.M. & Steckler, T. (2000) Behavioural analysis of four mouse strains in an anxiety test battery. Behav. Brain Res., 115, 95-106.
35. Zobel, A.W., Nickel, T., Künzel, H.E., Ackl, N., Sonntag, A., Ising, M. & Holsboer, F. (2000) Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: The first 20 patients treated. J. Psychiat. Res., 34, 171-181.